Fund Overview
Fund
Motilal Oswal Nifty MidSmall Healthcare Index Fund
Underlying Index: Nifty MidSmall HealthcareISIN: INF247L01EA7
11.507.01% (1Y)
End of Day NAV as on Oct 23, 2026
Fundamentals
| Asset Type | Equity |
| Underlying Index Type | Sectoral Index |
| No. of Companies | 30 Companies |
| Market Cap Focus | Mid & Small Cap |
| Std Deviation (1 yr) | 0.91% |
| P/E | 63.00 |
| P/B | 8.38 |
| Div Yield | 0.38% |
| Asset Type | Equity |
| Underlying Index Type | Sectoral Index |
| No. of Companies | 30 |
| Market Cap Focus | Mid & Small Cap |
| P/E | 63.00 |
| P/B | 8.38 |
| Div Yield | 0.38% |
| Std Deviation (1 yr) | 0.91% |
Fund Parameters
| AUM (Cr) | 53 |
| Base Expense Ratio | 0.54% |
| Tracking Error | 0.09% |
| All-In-Cost | 0.63% |
| Inception Date | 19 Nov 2024 |
| Scheme Plan - Option - Type | Direct Plan - Growth - Open ended scheme |
Native Score
| AUM (Cr) | 53 |
| Base Expense Ratio | 0.54% |
| Tracking Error | 0.09% |
| All-In-Cost | 0.63% |
| Inception Date | 19 Nov 2024 |
| Scheme Plan - Option - Type | Direct Plan - Growth - Open ended scheme |
| Native Score |
Similar Exchange Traded Funds (ETFs)
No similar exchange traded funds (etfs) available for this index
Similar Index Funds
| Fund Name | ||||||
|---|---|---|---|---|---|---|
| N/A | 221 | 0.37% | 0.09% | 0.46% |
Swipe to view more data →
| Fund Name | Last Close | AUM (Cr) | Avg Exp Ratio | Tracking Error | All-In-Cost | Score |
|---|---|---|---|---|---|---|
| N/A | 221 | 0.37% | 0.09% | 0.46% |
Sectoral Allocation
Total
100%
allocation
- Healthcare99.0%
- Business Services1.1%
- Miscellaneous0.8%
- Healthcare99.0%
- Business Services1.1%
- Miscellaneous0.8%
Fund Holdings
| Name | Weight |
|---|
| Laurus Labs Ltd. | 11.8% |
| Lupin Ltd. | 7.6% |
| Aurobindo Pharma Ltd. | 7.1% |
| Fortis Healthcare Ltd. | 6.2% |
| Glenmark Pharmaceuticals Ltd. | 5.4% |
| Alkem Laboratories Ltd. | 4.8% |
| Mankind Pharma Ltd. | 4.4% |
| Ipca Laboratories Ltd. | 4.1% |
| Biocon Ltd. | 4.0% |
| Gland Pharma Ltd. | 3.5% |
| Sai Life Sciences Ltd. | 3.2% |
| Krishna Institute of Medical Sciences Ltd | 3.1% |
| Aster DM Quality Care Ltd. | 2.9% |
| Neuland Laboratories Ltd. | 2.8% |
| Wockhardt Ltd. | 2.7% |
| Acutaas Chemicals Ltd. | 2.6% |
| Ajanta Pharma Ltd. | 2.5% |
| Dr. Lal Pathlabs Ltd. | 2.4% |
| Abbott India Ltd. | 2.2% |
| Piramal Pharma Ltd. | 2.0% |
| Granules India Ltd. | 1.9% |
| Narayana Hrudayalaya Ltd. | 1.9% |
| Global Health Ltd. | 1.9% |
| Onesource Specialty Pharma Ltd. | 1.8% |
| Glaxosmithkline Pharmaceuticals Ltd. | 1.8% |
| Anthem Biosciences Ltd. | 1.4% |
| Natco Pharma Ltd. | 1.1% |
| Cohance Lifesciences Ltd. | 1.1% |
| Syngene International Ltd. | 1.1% |
| Poly Medicure Ltd. | 1.0% |
| Tri-Party Repo (TREPS) | 0.8% |
| Net Current Asset | -0.8% |
NameWeight
Laurus Labs Ltd.11.8%
Lupin Ltd.7.6%
Aurobindo Pharma Ltd.7.1%
Fortis Healthcare Ltd.6.2%
Glenmark Pharmaceuticals Ltd.5.4%
Alkem Laboratories Ltd.4.8%
Mankind Pharma Ltd.4.4%
Ipca Laboratories Ltd.4.1%
Biocon Ltd.4.0%
Gland Pharma Ltd.3.5%
Sai Life Sciences Ltd.3.2%
Krishna Institute of Medical Sciences Ltd3.1%
Aster DM Quality Care Ltd.2.9%
Neuland Laboratories Ltd.2.8%
Wockhardt Ltd.2.7%
Acutaas Chemicals Ltd.2.6%
Ajanta Pharma Ltd.2.5%
Dr. Lal Pathlabs Ltd.2.4%
Abbott India Ltd.2.2%
Piramal Pharma Ltd.2.0%
Granules India Ltd.1.9%
Narayana Hrudayalaya Ltd.1.9%
Global Health Ltd.1.9%
Onesource Specialty Pharma Ltd.1.8%
Glaxosmithkline Pharmaceuticals Ltd.1.8%
Anthem Biosciences Ltd.1.4%
Natco Pharma Ltd.1.1%
Cohance Lifesciences Ltd.1.1%
Syngene International Ltd.1.1%
Poly Medicure Ltd.1.0%
Tri-Party Repo (TREPS)0.8%
Net Current Asset-0.8%
Holdings Concentration
Total covered: 101%
Top 1–5
5 holdings
38.0%
38%
share
Top 6–10
5 holdings
20.7%
21%
share
Top 11–20
10 holdings
26.3%
26%
share
Beyond 20
11 holdings
15.7%
16%
share
Market Cap Classification
Total
100%
allocation
- Mid Cap67.9%
- Small Cap32.2%
- Mid Cap67.9%
- Small Cap32.2%
Advanced Ratios
| Alpha | -0.01 |
| Beta | 1.00 |
| Sharpe Ratio | 0.06 |
| Sortino Ratio | 0.11 |
| Treynor Ratio | 0.06 |
| Information Ratio | -0.10 |
| Upside Capture | 99.27% |
| Downside Capture | 101.71% |
Index Methodology
| Factor Basis | Size (Market Cap), Sector/Theme |
| What universe selected from? | Nifty MidSmallcap 400 index |
| Weightage? | Periodic Capped Free Float Market Cap Weighting |
| Stocks Included | Maximum 30 companies. Top 30 mid &/or smallcap healthcare stocks based on six-month average free-float market capitalization are selected |
| Exclusions | Stocks Excluded from Nifty 500, Stocks not meeting criteria of top 30 based on Free Float market cap (Healthcare industry, Mid & Small Cap only); Non F&O Stocks hitting circuit limit in 20% of trading days over last 6months |
| Factor Basis | Size (Market Cap), Sector/Theme |
| Universe | Nifty MidSmallcap 400 index |
| Weightage | Periodic Capped Free Float Market Cap Weighting |
| Stocks Included | Maximum 30 companies. Top 30 mid &/or smallcap healthcare stocks based on six-month average free-float market capitalization are selected |
| Exclusions | Stocks Excluded from Nifty 500, Stocks not meeting criteria of top 30 based on Free Float market cap (Healthcare industry, Mid & Small Cap only); Non F&O Stocks hitting circuit limit in 20% of trading days over last 6months |
Fund • Last updated: 25/10/2026